Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biomolecules|January 12, 2016
Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer TreatmentTsz-Lun Yeung, Cecilia S Leung, Fuhai Li, et al.
Oncotarget|February 16, 2017
ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cellsTsz-Lun Yeung, Cecilia S Leung, Kwong-Kwok Wong, et al.
American Journal of Physiology. Cell Physiology|July 31, 2015
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer MetastasisTsz-Lun Yeung, Cecilia S Leung, Kay-Pong Yip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2019
Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic CancerTsz-Lun Yeung, Cecilia S Leung, Kay-Pong Yip, et al.
Journal of the National Cancer Institute|June 4, 2018
Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian CancerTsz-Lun Yeung, Jianting Sheng, Cecilia S Leung, et al.
Cancers|November 25, 2018
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer ProgressionTsz-Lun Yeung, Ching Chou Tsai, Cecilia S Leung, et al.
The Journal of Clinical Investigation|December 19, 2017
Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistanceCecilia S Leung, Tsz-Lun Yeung, Kay-Pong Yip, et al.
Nature Communications|March 30, 2016
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1Chi Lam Au Yeung, Ngai-Na Co, Tetsushi Tsuruga, et al.
Nature Communications|October 4, 2014
Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potentialCecilia S Leung, Tsz-Lun Yeung, Kay-Pong Yip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2013
Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancerTarrik M Zaid, Tsz-Lun Yeung, Melissa S Thompson, et al.
Pageof 2